» Articles » PMID: 15530367

Crystal Structures of Ral-GppNHp and Ral-GDP Reveal Two Binding Sites That Are Also Present in Ras and Rap

Overview
Journal Structure
Publisher Cell Press
Date 2004 Nov 9
PMID 15530367
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

RalA is a GTPase with effectors such as Sec5 and Exo84 in the exocyst complex and RalBP1, a GAP for Rho proteins. We report the crystal structures of Ral-GppNHp and Ral-GDP. Disordered switch I and switch II, located away from crystal contacts, are observed in one of the molecules in the asymmetric unit of the Ral-GppNHp structure. In the other molecule in the asymmetric unit, a second Mg(2+) ion is bound to the GppNHp gamma-phosphate in an environment in which switch I is pulled away from the nucleotide and switch II is found in a tight beta turn. Clustering of conserved residues on the surface of Ral-GppNHp identifies two putative sites for protein-protein interaction. One site is adjacent to switch I. The other is modulated by switch II and is obstructed in Ral-GDP. The Ral structures are discussed in the context of the published structures of the Ral/Sec5 complex, Ras, and Rap.

Citing Articles

The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.

Richardson D, Spehar J, Han D, Chakravarthy P, Sizemore S Cells. 2022; 11(10).

PMID: 35626682 PMC: 9139244. DOI: 10.3390/cells11101645.


Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.

Bum-Erdene K, Ghozayel M, Xu D, Meroueh S ChemMedChem. 2022; 17(6):e202100750.

PMID: 35061330 PMC: 9070689. DOI: 10.1002/cmdc.202100750.


Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.

Bum-Erdene K, Liu D, Gonzalez-Gutierrez G, Ghozayel M, Xu D, Meroueh S Proc Natl Acad Sci U S A. 2020; 117(13):7131-7139.

PMID: 32179690 PMC: 7132301. DOI: 10.1073/pnas.1913654117.


Conformational resolution of nucleotide cycling and effector interactions for multiple small GTPases determined in parallel.

Killoran R, Smith M J Biol Chem. 2019; 294(25):9937-9948.

PMID: 31088913 PMC: 6597838. DOI: 10.1074/jbc.RA119.008653.


RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.

Yan C, Theodorescu D Pharmacol Rev. 2017; 70(1):1-11.

PMID: 29196555 PMC: 5712631. DOI: 10.1124/pr.117.014415.